Liver Transplantation
📧 Sign up to get email alerts when something new happens for Liver Transplantation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2010-09-10Clinical Trial Update: Withdrawal of Immunosuppression in Long Term Stable Liver Transplant Recipients [Phase 2]
Phase 2 clinical trial investigating withdrawal of immunosuppression in long-term stable liver transplant recipients; current status is unkn…
-
CLINICAL_TRIALS trial_result · 2010-08-25Clinical Trial Update: An Open, Randomized Pilot Study to Evaluate the Use of Basiliximab With an Optimized Cyclosporine Dosing on Renal Function in "de Novo" Liver Transplantation. [Phase 4]
An open, randomized Phase 4 pilot trial evaluated using Basiliximab with optimized cyclosporine dosing in patients undergoing de novo liver …
-
FDA approval · 2010-06-10FDA Approved: MYCOPHENOLATE MOFETIL — Original Application (Strides Pharma Science Limited)
FDA approved a generic version of mycophenolate mofetil under an Original Application by Strides Pharma Science Limited. Indications include…
-
CLINICAL_TRIALS trial_result · 2010-04-16Clinical Trial Update: Pharmacokinetics of Tacrolimus in Liver Transplantation Patients Treated With Prograf and Modified Release Tacrolimus [Phase 3]
Phase 3 trial update examining the pharmacokinetics of tacrolimus in liver transplant patients treated with Prograf and a modified-release f…
-
FDA approval · 2009-11-30FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for Accord Healthcare's generic mycophenolate mofetil. The product is used to prevent organ transpla…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-10-08FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
FDA approved Genentech's supplemental application for Cellcept (mycophenolate mofetil hydrochloride).
-
CLINICAL_TRIALS trial_result · 2009-09-18Clinical Trial Update: Post-Operative Use of Salt Poor Albumin Solution in Resuscitation of Orthotopic Liver Transplant [NA]
A clinical trial update evaluating the post-operative use of Salt Poor Albumin Solution for resuscitation in liver transplant patients.
-
FDA approval · 2009-05-04FDA Approved: MYCOPHENOLATE MOFETIL — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved an original application for a generic mycophenolate mofetil manufactured by Mylan Pharmaceuticals Inc, for organ transplant rej…
-
FDA approval · 2009-02-13FDA Approved: PROGRAF — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for PROGRAF (tacrolimus) from Astellas Pharma US, Inc., indicating an approved change to the existin…
-
CLINICAL_TRIALS trial_result · 2008-12-17Clinical Trial Update: Prospective Study of Drug Resistant Pathogens Among Liver, Intestinal and Multivisceral Transplant Recipients
A completed prospective study examining the incidence and characteristics of drug-resistant pathogens in liver, intestinal, and multiviscera…
-
CLINICAL_TRIALS trial_result · 2008-07-22Clinical Trial Update: A Study to Assess the Safety and Efficacy of Prograf and MR4 in Liver Transplant Recipients [Phase 3]
Phase 3 trial assessing the safety and efficacy of Prograf (tacrolimus) with MR4 in liver transplant recipients has completed. The study was…
-
CLINICAL_TRIALS trial_result · 2008-04-17Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of FK778 in Liver Transplant Patients [Phase 2]
Phase 2 clinical trial evaluating safety and effectiveness of FK778 in liver transplant patients has completed.
-
CLINICAL_TRIALS trial_result · 2008-04-16Clinical Trial Update: Comparison of Quantiferon-TB Gold Assay With Tuberculin Skin Testing in Patients With Chronic Liver Disease [Phase 4]
Phase 4 trial update comparing the Quantiferon-TB Gold assay with tuberculin skin testing in patients with chronic liver disease, including …
-
FDA approval · 2007-12-20FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for CellCept to update labeling, expanding its use for prevention of organ transplant rejection in r…
-
CLINICAL_TRIALS trial_result · 2007-11-26Clinical Trial Update: Evaluation of Celsior® in Liver Transplant Preservation. [Phase 2]
The update reports the completion of a Phase 2 trial evaluating Celsior® for liver transplant preservation.
-
FDA approval · 2007-10-17FDA Approved: SIROLIMUS — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Sirolimus from Mylan Pharmaceuticals Inc., indicating an approved change or addition to the prod…
-
FDA approval · 2007-09-21FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for CellCept (mycophenolate mofetil) from Genentech, Inc., likely resulting in an updated indica…
-
FDA approval · 2007-05-02FDA Approved: SIROLIMUS — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for sirolimus submitted by Mylan Pharmaceuticals Inc., resulting in changes to the labeling and/…
-
CLINICAL_TRIALS trial_result · 2007-04-19Clinical Trial Update: PK of MMF in Cadaveric vs Living Donor Liver Transplant Recipients [Phase 4]
Phase 4 study examining the pharmacokinetics of mycophenolate mofetil in cadaveric versus living donor liver transplant recipients has compl…
-
CLINICAL_TRIALS research · 2007-02-19Clinical Trial Update: Pneumonia Vaccine in Liver Transplant Recipients: a Booster Strategy Using a Conjugate Vaccine [Phase 4]
This update discusses a Phase 4 study evaluating a booster strategy with a pneumococcal conjugate vaccine in liver transplant recipients to …
-
FDA approval · 2007-01-09FDA Approved: SIROLIMUS — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for sirolimus from Mylan Pharmaceuticals Inc., authorizing changes to the existing product appro…